Global Business Innovation Programme | Innovate UK EDGE (ukri.org)
Canada has significant strengths in life sciences research and innovation, especially in RNA production and next generation medicines, such as cell therapy, gene therapy and regenerative medicine. Canada has also recently launched a new biomanufacturing and life sciences strategy, backed by over $2.2 billion investment, with clear ambitions to grow its vaccine, therapeutics and biomanufacturing capacity, ensuring a strong and competitive sector and pandemic readiness for years to come.
Briefing event tomorrow but will be recorded so can watch again
GBIP Canada, Biomanufacturing of Advanced Therapies – Applicant Briefing Tickets, Tue 1 Mar 2022 at 15:00 | Eventbrite
Applications close 31st March
GLOBAL BUSINESS INNOVATION PROGRAMME – APPLICATION FORM CANADA 2022 – BIOMANUFACTURING (Page 1 of 8) (office.com)
